{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:37:52Z","timestamp":1776836272645,"version":"3.51.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alterations in the gut microbiota have been reported in various malignancies, but its role in laryngeal squamous cell carcinoma (LSCC) remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 101 patients undergoing laryngeal surgery (46 benign, 55 malignant). Preoperative fecal samples were collected and subjected to 5R 16S rRNA sequencing. Sequencing data were processed using DADA2 and QIIME2, followed by \u03b1\/\u03b2 diversity analysis, differential abundance detection (Wilcoxon test, LEfSe, random forest), and LASSO regression. Functional pathway differences were inferred using PICRUSt2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      There were no significant differences in \u03b1 diversity metrics between groups, whereas \u03b2 diversity analysis revealed significant separation between Benign and LSCC (PERMANOVA, P&amp;lt;0.01). Distinct community composition differences were observed: Malignant cases showed enrichment of genera such as\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      , while Benign cases exhibited enrichment of genera including\n                      <jats:italic>Bacteroides<\/jats:italic>\n                      and\n                      <jats:italic>Lachnospira<\/jats:italic>\n                      . Multimethod integration identified 17 core bacterial genera, which were further refined via LASSO regression to select a stable set of genera (e.g.,\n                      <jats:italic>Streptococcus<\/jats:italic>\n                      ,\n                      <jats:italic>Eubacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Lachnospira<\/jats:italic>\n                      ) capable of reliably distinguishing benign from malignant cases. The logistic regression model based on stable genera demonstrated excellent diagnostic performance (AUC &amp;gt; 0.8), particularly in distinguishing benign from LateLSCC. Functional prediction revealed pathway imbalances: malignant cases showed enrichment in cell wall and amino acid synthesis pathways, while benign cases favored vitamin and steroid metabolism pathways.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LSCC patients exhibit structural remodeling of their gut microbiota, characterized by distinct taxonomic and functional alterations. Stable microbial signatures holding potential as a foundation for the future development of non-invasive diagnostic and staging biomarkers, though their clinical translation necessitates further large-scale validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1788705","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:39:09Z","timestamp":1776832749000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiome restructuring in laryngeal squamous cell carcinoma identifies stable microbial biomarkers with diagnostic potential"],"prefix":"10.3389","volume":"16","author":[{"given":"Jiaming","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine","place":["Tianjin, China"]},{"name":"Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology","place":["Tianjin, China"]},{"name":"Graduate School, Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingtai","family":"Zhi","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine","place":["Tianjin, China"]},{"name":"Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Li","sequence":"additional","affiliation":[{"name":"LC-Bio Technology Co., Ltd.","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine","place":["Tianjin, China"]},{"name":"Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengchi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine","place":["Tianjin, China"]},{"name":"Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juntao","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, The Second Hospital of Tianjin Medical University","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, Tianjin First Central Hospital","place":["Tianjin, China"]},{"name":"Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine","place":["Tianjin, China"]},{"name":"Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000902","article-title":"Updated disease distributions, risk factors, and trends of laryngeal cancer: a global analysis of cancer registries","volume":"110","author":"Huang","year":"2024","journal-title":"Int J Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c06930","article-title":"Targeting metastasis in head and neck squamous cell carcinoma using follistatin mRNA lipid nanoparticles","volume":"18","author":"Grigoriev","year":"2024","journal-title":"ACS Nano"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00766-x","article-title":"Gut microbiota in colorectal cancer development and therapy","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00531-9","article-title":"Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment","volume":"23","author":"Ruffin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13045-024-01541-w","article-title":"Critical role of the gut microbiota in immune responses and cancer immunotherapy","volume":"17","author":"Li","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s40168-024-01924-8","article-title":"Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis","volume":"12","author":"Kang","year":"2024","journal-title":"Microbiome"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2024.06.003","article-title":"Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment","volume":"35","author":"Yu","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41392-025-02159-1","article-title":"Gut dysbiosis conveys psychological stress to activate LRP5\/\u03b2-catenin pathway promoting cancer stemness","volume":"10","author":"Cui","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/s41467-023-38058-8","article-title":"Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions","volume":"14","author":"Seelbinder","year":"2023","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","article-title":"The gut microbiome and cancer: from tumorigenesis to therapy","volume":"7","author":"Nobels","year":"2025","journal-title":"Nat Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41522-025-00708-8","article-title":"Oral microbiome-derived biomarkers for non-invasive diagnosis of head and neck squamous cell carcinoma","volume":"11","author":"Zhi","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042320-021020","article-title":"The gut microbiome and inflammatory bowel diseases","volume":"73","author":"Shan","year":"2022","journal-title":"Annu Rev Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","article-title":"NCCN guidelines\u00ae Insights: head and neck cancers, version 2.2025","volume":"23","author":"Colevas","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2201159","article-title":"A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma","volume":"15","author":"Yang","year":"2023","journal-title":"Gut Microbes"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000005773","article-title":"Statistics from A (agreement) to Z (z score): A guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research","volume":"133","author":"Schober","year":"2021","journal-title":"Anesth Analg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"qzaf072","DOI":"10.1093\/gpbjnl\/qzaf072","article-title":"The GSA family in 2025: A broadened sharing platform for multi-omics and multimodal data","volume":"23","author":"Zhang","year":"2025","journal-title":"Genomics Proteomics Bioinf"},{"key":"B23","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","article-title":"Database resources of the national genomics data center, China national center for bioinformation in 2025","volume":"53","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07754-w","article-title":"Gut microbiota carcinogen metabolism causes distal tissue tumours","volume":"632","author":"Roje","year":"2024","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101478","article-title":"Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy","volume":"5","author":"Kang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306776121","article-title":"A high-fat diet promotes cancer progression by inducing gut microbiota-mediated leucine production and PMN-MDSC differentiation","volume":"121","author":"Chen","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501818","article-title":"A peripheral mechanism of depression: Disturbed intestinal epithelial Per2 gene expression causes depressive behaviors in mice with circadian rhythm disruption via gut barrier damage and microbiota dysbiosis","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309032120","article-title":"Bacterial indole-3-lactic acid affects epithelium-macrophage crosstalk to regulate intestinal homeostasis","volume":"120","author":"Yu","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01913-0","article-title":"Drivers and determinants of strain dynamics following fecal microbiota transplantation","volume":"28","author":"Schmidt","year":"2022","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2555446","article-title":"A new gut pathogenic bacteria and its metabolites promote colorectal cancer development and act as non-invasive early diagnostic biomarkers","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2517828","article-title":"Fecal gut microbiota and amino acids as noninvasive diagnostic biomarkers of pediatric inflammatory bowel disease","volume":"17","author":"Vermeer","year":"2025","journal-title":"Gut Microbes"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.cell.2025.03.010","article-title":"Conserved genetic basis for microbial colonization of the gut","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113324","article-title":"Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population","volume":"42","author":"Tomofuji","year":"2023","journal-title":"Cell Rep"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1788705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:39:15Z","timestamp":1776832755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1788705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1788705"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1788705","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1788705"}}